Search & Evaluation and Business Development Lead, EUCAN Oncology

By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms of Use. I further attest that all information I submit in my employment application is true to the best of my knowledge.

Job Description

Takeda has a broad and growing oncology pipeline that will build upon our strong commercial foundation in both solid cancer and hematologic malignancies. Business development (BD) will be core to further strengthen Takeda’s foothold in oncology by continuously evaluating opportunities for in-licensing, out-licensing, co-promotions, research collaborations and other partnerships. Therefore, Takeda is seeking an Oncology Search & Evaluation & Business Development Lead focused on Europe and Canada, to work as part of an international and integrated team.

OBJECTIVES:

• Main partners for this role within Takeda include the New Product Planning (NPP) in the Global Oncology Business Unit (GOBU), the Oncology team in Europe and Canada, our Center for External Innovation (CEI), Global Business Development (GBD), and our disease area strategy teams.
• This role will be responsible for helping drive Takeda’s oncology strategy through evaluation of new therapeutic assets and collaboration opportunities, co-owning the oncology BD target list, orchestrating valuations, communicating & influencing, and supporting BD processes from initial search to deal closure.

ACCOUNTABILITES:

Corporate and strategic objectives of Takeda Oncology Business Unit

• Proactively support shaping and driving Takeda’s oncology portfolio strategy by owning key externally facing activities to grow a late-stage oncology pipeline and build disease area awareness, presence & capabilities
• Engage senior oncology leadership to deliver on the OBU portfolio strategy and business development targets
• Build the capability and function to perform Search & Evaluation and Business Development & Licensing, with a focus on Oncology in Europe

Search & Screen

• Own and proactively execute the search and triaging process, primarily but not limited to in Europe, of external oncology partnership opportunities by participating in & synthesizing stakeholder feedback from partnering and key scientific conferences
• Manage and continuously refine the process, primarily but not limited to Europe, for regular landscape screening efforts to grow Takeda’s external oncology knowledge base and identify novel targets

Valuation

• Coordinate, lead, and assess licensing, co-promotion, and acquisition opportunities with evidence-based recommendations by synthesizing clinical, scientific, regulatory, medical (KOL), patent and public commercial information – ensuring clear ownership of value-driving assumptions with main stakeholders
• Translate asset valuation insights into forecast and financial models and partner with forecasting, finance, competitive intelligence, commercial and other functions to inform term sheet structure, financing, and negotiations

Communication & Influence

• Communicate and champion key messages & business rationale from asset valuations (value drivers, inflections points, key risks, and potential red flags, etc.), external innovation screenings and both their implications for oncology strategy
• Own and drive opportunities end-to-end through project phases, governance bodies and stage-gate decisions by
  • Influencing and helping to generate buy-in from relevant stakeholders and senior management absent of specific authority, but by advising & consulting on key strategic and business development questions
  • Managing and/or contributing to matrixed project teams across functions and geographies
  • Preparing concise and powerful documentation to support discussion and decision making

Confirmatory diligence & transaction support

• Coordinate cross-functional teams on confirmatory due diligence efforts and own value-driving diligence streams, ensuring consistent assessment structure and comparability across different asset diligence outputs
• Inform and steer deal structuring, negotiation strategy and support process from term sheet to final contracting

Takeda oncology capabilities and network

• Maintain and expand Takeda’s internal knowledge base in areas of scientific, clinical, and strategic interest by synthesizing and structuring insights from asset valuations, conference attendance, market research, etc.
• Grow and strengthen existing business relationship with core stakeholders internally and externally of OBU

EDUCATION, EXPERIENCE, KNOWLEDGE AND SKILLS:

• Master’s or graduate degree in a scientific discipline
• Pharmaceutical / biotech search and valuation, and / or pharmaceutical portfolio / corporate strategy experience. Experience in healthcare investment banking, strategy consulting or pharma equity analysis will also be considered, as well as MBA or similar.
• Strong understanding of the clinical drug development, regulatory, access, and commercialization process; with a preference for previous oncology / hematology experience
• Strong forecasting and financial valuation experience in the pharma context, including basic financial and accounting knowledge (P&L forecasting, DCF valuations, etc.)
• Results-oriented, creative, self-starter with strong verbal and written communication and presentation skills; experience in preparing materials and presenting to executive management desirable.
• Excellent interpersonal skills, proven leadership capabilities and experience leading teams and influencing cross-functional groups (R&D, M&A) in a global setting (cross-cultural experience desirable)
• Location: Zurich, Switzerland

TRAVEL REQUIREMENTS

• Willingness to travel to various meetings or client sites, including overnight trips. Some international travel may be required.
• Requires approximately 10-20% travel.

Locations

Worker Type

Worker Sub-Type

Time Type